I betragtning af hyppigheden af gastrointestinale bivirkninger ved behandlingen med Diacomit og valproat (anoreksi, appetitløshed, nausea, opkastning), bør vækstraten hos børn i denne behandlingskombination overvåges nøje.
Given the frequency of gastrointestinal adverse reactions to treatment with Diacomit and valproate (anorexia, loss of appetite, nausea, vomiting), the growth rate of children under this combination of treatment should be carefully monitored.